Ravinderjit Braich, Ph.D.

What do you focus on?

I focus my practice on helping clients, including hospitals, research institutes and small and medium size companies, devise and pursue effective strategies for protecting their breakthrough technologies. I have experience in a wide range of technologies including small molecules, nucleic acid based technologies (RNAi, activating RNAs, antisense nucleic acids and microRNAs), peptides, antibodies, prodrugs and drug conjugates, anesthetics, diagnostic/imaging agents, antiviral agents, cancer vaccines, semi-conductor materials, drug targeting and drug delivery, microfluidic devices, drug delivery devices, diagnostic devices and biomimetic devices. This work involves their synthesis, purification, and use.

Patent Prosecution

I focus on strategic patent counseling and prosecution in areas of chemical, diagnostics, therapeutics and pharmaceuticals in all phases of development, within and outside the United States.

Patent Portfolio Management

I work closely with corporations, universities and licensee counsel on strategic management and growth of their patent portfolios.

Opinion Work

I work with clients in varieties of industries to conduct patentability and freedom to operate analysis, and competitive intelligence and analysis in areas of small molecules, nucleic acids, polymers and diagnostic methods and devices.

What do you see on the horizon?

I believe that more patent owners, not just pharmaceutical companies, will look to create sovereign immunity claims for fending of inter partes review (IPR) before the Patent Trial and Appeal Board.

Representative Matters

• Provide a broad range of patent services, including patent portfolio management, to a start-up company involved in cancer therapeutics and targeted drug delivery; work closely with the client in the strategic development of their IP portfolio.

• Helped develop a patent portfolio directed to new anesthetics for a large hospital-based research organization; work with the client and licensee in devising and executing strategies that will extract the greatest value from the portfolio.